Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-25T17:39:47.393Z Has data issue: false hasContentIssue false
  • English
  • Français

Input from our Readers

Published online by Cambridge University Press:  07 November 2014

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
CNS Spectrums , Volume 3 , Issue 2: Pathophysiologic and Clinical Progress in Parkinson's Disease , February 1998 , pp. 66 - 68
Copyright
Copyright © Cambridge University Press 1998

References

REFERENCES

1.Marder, SR. Management of treatment-resistant patients with schizophrenia. J Clin Psychiatry. 1996;57:26–30.Google ScholarPubMed
2.Beasley, CM Jr, Tollefson, G, Tran, P, Satterlee, W, Sanger, T, Hamilton, S. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology. 1996;14:111–126.CrossRefGoogle ScholarPubMed
3.Jane, J, Honigfeld, G, Singer, J, Meltzer, H, and the Clozaril Collaborative Study Group. Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789–796.Google Scholar
4.Owens, DG. Adverse effects of antipsychotic agents. Do newer agents offer advantages? Drugs. 1996;51:895–930.CrossRefGoogle ScholarPubMed
5.Richelson, E. Preclinical pharmacology of neuroleptics: focus on new generation compound. J Clin Psychiatry. 1996;57:4–11.Google Scholar
6.Beasley, CM. Efficacy of olanzapine: an overview of pivotal clinical trials. J Clin Psychiatry. 1997;15:16–18.Google Scholar
7.Borison, RL. Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics. J Clinical Psychopharmacol. 1995;15:24S–29S.CrossRefGoogle ScholarPubMed
8.Tollefson, GD, Beasley, CM, Tran, PV, et al.Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trail. Am J Psychiatry. 1997;154:457–465.Google Scholar
1.McGlashan, T. Schizophrenia and obsessive-compulsive disorder: are they related disorders? CNS Spectrums. 1997;2:16–18.CrossRefGoogle Scholar
2.Schwartz, MA. Obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143:1323–1324.CrossRefGoogle ScholarPubMed
3.Institoris, H. Malleus Maleficarum (The Witches' Hammer, 1487). Translated by the Rev.Summers, MantagueLondon, UK: Pushkin; 1928.Google Scholar
4.Jaspers, K. General Psychopathology. Chicago, Ill: University of Chicago Press; 1968.Google Scholar